Pure Global

Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME) - Trial NCT05712720

Access comprehensive clinical trial information for NCT05712720 through Pure Global AI's free database. This Phase 2 trial is sponsored by Rezolute and is currently Recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05712720
Phase 2
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT05712720
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
A Randomized, Double-Masked, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ402 in Participants With Diabetic Macular Edema (DME)

Study Focus

Diabetic Macular Edema

Experimental: Group 1

Interventional

drug

Sponsor & Location

Rezolute

Phoenix,Beverly Hills,Fullerton,Modesto,Santa Barbara,Coral Springs,Winter Haven,Augusta,Oak Forest,Hagerstown,Royal Oak,Saint Louis Park,Saint Louis,Reno,Bloomfield,Great Neck,New York,Springfield,La, United States of America

Timeline & Enrollment

Phase 2

Feb 06, 2023

Jan 01, 2024

100 participants

Primary Outcome

Safety Events,Change in Central Subfield Thickness

Summary

The objective of this trial is to assess the safety, efficacy, and tolerability of RZ402 in
 patients with Diabetic Macular Edema.

ICD-10 Classifications

Diabetic retinopathy
Other specified diabetes mellitus with ophthalmic complications
Unspecified diabetes mellitus with ophthalmic complications
Diabetic cataract
Type 2 diabetes mellitus with ophthalmic complications

Data Source

ClinicalTrials.gov

NCT05712720

Non-Device Trial